Literature DB >> 738406

Interaction between azapropazone and warfarin.

J C McElnay, P F D'Arcy.   

Abstract

In vitro studies, using 2 separate techniques, have shown that the anti-inflammatory agent azapropazone caused displacement of warfarin from its plasma albumin binding and it is therfore suggested that such a displacement mechanism may be involved in the reported clinical interaction between these 2 drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 738406     DOI: 10.1007/bf01981445

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  7 in total

1.  Drug displacement of warfarin from human serum albumin: a fluorometric analysis.

Authors:  R A Henry; W D Wosilait
Journal:  Toxicol Appl Pharmacol       Date:  1975-08       Impact factor: 4.219

2.  Interaction between azapropazone and warfarin.

Authors:  J C McElnay; P F D'Arcy
Journal:  Br Med J       Date:  1977-09-17

3.  Interaction between azapropazone and warfarin.

Authors:  P R Powell-Jackson
Journal:  Br Med J       Date:  1977-05-07

Review 4.  Drug therapy. Binding of drugs to serum albumin (second of two parts).

Authors:  J Koch-Weser; E M Sellers
Journal:  N Engl J Med       Date:  1976-03-04       Impact factor: 91.245

5.  Potentiation of anticoagulant effect of warfarin by phenylbutazone.

Authors:  P M Aggeler; R A O'Reilly; L Leong; P E Kowitz
Journal:  N Engl J Med       Date:  1967-03-02       Impact factor: 91.245

6.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

7.  Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids.

Authors:  E M Sellers; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1970 Jul-Aug       Impact factor: 6.875

  7 in total
  2 in total

Review 1.  Protein binding displacement interactions and their clinical importance.

Authors:  J C McElnay; P F D'Arcy
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

2.  Hypoglycaemia induced by azapropazone-tolbutamide interaction.

Authors:  P B Andreasen; K Simonsen; K Brocks; B Dimo; P Bouchelouche
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.